相关实验视频

Updated: Sep 13, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

在冠状动脉疾病中,MiR-4429通过准GNAI2作为保护性调节剂

Yu Chen¹, Siyuan Yang¹, Yifan Niu¹

¹Department of Cardiology, Northern Jiangsu People's Hospital.

International heart journal

|July 30, 2025

概括

这项研究在冠状动脉疾病 (CAD) 患者中发现了较低的miR-4429水平,将其确定为潜在的诊断生物标志物. 恢复 miR-4429 保护人类细胞免受炎症和细胞损伤.

科学领域:

心血管生物学心血管生物学
分子医学是分子医学.
生物标志物发现发现

背景情况:

微RNAs (miRNAs) 越来越多地被认为是冠状动脉疾病 (CAD) 病原体中的角色.
特定miRNAs的失调可以促进心血管疾病的发展和进展.

研究的目的:

在CAD患者的血清中研究miR-4429的表达水平.
在CAD中探索miR-4429及其目标基因GNAI2的功能作用.
评估miR-4429在CAD中的诊断潜力.

主要方法:

定量实时PCR (qRT-PCR) 用于测量miR-4429的表达.
接收器操作特征 (ROC) 曲线分析和用于诊断性能的后勤回归.
在氧化低密度脂蛋白 (ox-LDL) 诱导的人静脉内皮细胞 (HUVEC) 中进行细胞增殖 (CCK-8) 和亡测定.
双露西法酶记者测定证实了miR-4429/GNAI2的相互作用.

主要成果:

在CAD患者和用牛LDL治疗的HUVEC患者中,miR-4429水平显著降低,而GNAI2水平增加.
miR-4429表达与白细胞 (WBC) 计数和C反应蛋白 (CRP) 水平负相关.
ROC分析表明miR-4429和GNAI2是CAD的有效诊断标记物和独立预测因素.
在HUVEC中恢复miR-4429逆转了ox-LDL诱导的炎症 (IL-6,MCP-1,ICAM-1),抑制了增殖,并促进了亡.
证实GNAI2是miR-4429的直接标,其上调抵消了miR-4429的保护作用.

结论:

miR-4429作为CAD的有前途的诊断生物标志物,与全身炎症标志物相关.
miR-4429通过向GNAI2.2,表现出对氧-LDL诱导的内皮细胞功能障碍的保护作用.
针对miR-4429/GNAI2轴可能为CAD提供治疗策略.

关键词:

炎症反应的炎症反应增殖和亡是它们的生长过程.

更多相关视频

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...